- Home
- FENC vs GDEV Comparison
FENC vs GDEV Comparison
Compare FENC & GDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$7.57
HOLD
Current Price
$16.58
Company Overview
Basic Information| Metric | FENC | GDEV |
|---|---|---|
| Founded | 1996 | 2009 |
| Country | United States | Cyprus |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 276.3M | 308.9M |
| IPO Year | 2001 | N/A |
Fundamental Metrics
Financial Performance| Metric | FENC | GDEV |
|---|---|---|
| Price | $7.57 | $16.58 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 179.1K | 1.9K |
| Earning Date | 03-09-2026 | 11-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 50.98 |
| EPS | N/A | ★ 3.08 |
| Revenue | $38,790,000.00 | ★ $412,018,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $70.97 | $4.89 |
| P/E Ratio | ★ N/A | $5.38 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.68 | $8.60 |
| 52 Week High | $9.92 | $42.20 |
Technical Indicators
Market Signals| Indicator | FENC | GDEV |
|---|---|---|
| Relative Strength Index (RSI) | 48.02 | 49.36 |
| Support Level | $7.35 | $14.60 |
| Resistance Level | $7.82 | $15.40 |
| Average True Range (ATR) | 0.39 | 0.34 |
| MACD | 0.00 | 0.25 |
| Stochastic Oscillator | 31.06 | 66.03 |
Price Performance
Historical Comparison FENC
GDEV
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About GDEV GDEV Inc.
GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.